These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 36140405)

  • 41. A novel multi-epitope vaccine based on Dipeptidyl Peptidase 4 prevents streptozotocin-induced diabetes by producing anti-DPP4 antibody and immunomodulatory effect in C57BL/6J mice.
    Li Z; Fang J; Jiao R; Wei X; Ma Y; Liu X; Cheng P; Li T
    Biomed Pharmacother; 2017 May; 89():1467-1475. PubMed ID: 28376584
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hypoxia Alters the Expression of Dipeptidyl Peptidase 4 and Induces Developmental Remodeling of Human Preadipocytes.
    Chowdhury HH; Velebit J; Radić N; Frančič V; Kreft M; Zorec R
    J Diabetes Res; 2016; 2016():7481470. PubMed ID: 26881257
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A haplotype in the dipeptidyl peptidase 4 gene impacts glycemic-related traits of Brazilian older adults.
    Alves ES; Tonet-Furioso AC; Alves VP; Moraes CF; Pérez DIV; Bastos IMD; Córdova C; Nóbrega OT
    Braz J Med Biol Res; 2022; 55():e12148. PubMed ID: 36197412
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dipeptidyl Peptidase-4 at the Interface Between Inflammation and Metabolism.
    Trzaskalski NA; Fadzeyeva E; Mulvihill EE
    Clin Med Insights Endocrinol Diabetes; 2020; 13():1179551420912972. PubMed ID: 32231442
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CD26/DPP4 levels in peripheral blood and T cells in patients with type 2 diabetes mellitus.
    Lee SA; Kim YR; Yang EJ; Kwon EJ; Kim SH; Kang SH; Park DB; Oh BC; Kim J; Heo ST; Koh G; Lee DH
    J Clin Endocrinol Metab; 2013 Jun; 98(6):2553-61. PubMed ID: 23539735
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Roles of Dipeptidyl Peptidase 4 (DPP4) and DPP4 Inhibitors in Different Lung Diseases: New Evidence.
    Zhang T; Tong X; Zhang S; Wang D; Wang L; Wang Q; Fan H
    Front Pharmacol; 2021; 12():731453. PubMed ID: 34955820
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Systemic Hypoxia Increases the Expression of DPP4 in Preadipocytes of Healthy Human Participants.
    Chowdhury HH; Velebit J; Mekjavic IB; Eiken O; Kreft M; Zorec R
    Exp Clin Endocrinol Diabetes; 2018 Feb; 126(2):91-95. PubMed ID: 28950392
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Circulating Concentrations of Cathelicidin Anti-Microbial Peptide (CAMP) Are Increased during Oral Glucose Tolerance Test.
    Höpfinger A; Karrasch T; Schäffler A; Schmid A
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629082
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Incretin receptors for glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide are essential for the sustained metabolic actions of vildagliptin in mice.
    Flock G; Baggio LL; Longuet C; Drucker DJ
    Diabetes; 2007 Dec; 56(12):3006-13. PubMed ID: 17717280
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biological function of dipeptidyl peptidase-4 on type 2 diabetes patients and diabetic mice.
    Qiao J; Li L; Ma Y; Shi R; Teng M
    Curr Res Transl Med; 2019 Aug; 67(3):89-92. PubMed ID: 30591375
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of DPP-4: a new therapeutic approach for the treatment of type 2 diabetes.
    Pratley RE; Salsali A
    Curr Med Res Opin; 2007 Apr; 23(4):919-31. PubMed ID: 17407649
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The incretin effect and type 2 diabetes].
    Quintanilla-García C; Zúñiga-Guajardo S
    Rev Med Inst Mex Seguro Soc; 2010; 48(5):509-20. PubMed ID: 21205499
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Circulating dipeptidyl peptidase-4 is independently associated with the presence and severity of NAFLD/NASH in individuals with and without obesity and metabolic disease.
    Barchetta I; Ceccarelli V; Cimini FA; Barone E; Sentinelli F; Coluzzi M; Chiappetta C; Bertoccini L; Tramutola A; Labbadia G; Di Cristofano C; Silecchia G; Leonetti F; Cavallo MG
    J Endocrinol Invest; 2021 May; 44(5):979-988. PubMed ID: 32852705
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nrg4 promotes fuel oxidation and a healthy adipokine profile to ameliorate diet-induced metabolic disorders.
    Chen Z; Wang GX; Ma SL; Jung DY; Ha H; Altamimi T; Zhao XY; Guo L; Zhang P; Hu CR; Cheng JX; Lopaschuk GD; Kim JK; Lin JD
    Mol Metab; 2017 Aug; 6(8):863-872. PubMed ID: 28752050
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association of plasma dipeptidyl peptidase-4 activity with non-alcoholic fatty liver disease in nondiabetic Chinese population.
    Zheng T; Chen B; Yang L; Hu X; Zhang X; Liu H; Qin L
    Metabolism; 2017 Aug; 73():125-134. PubMed ID: 28637594
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mechanisms of neurodegeration in type 2 diabetes and the neuroprotective potential of dipeptidyl peptidase 4 inhibitors.
    Matteucci E; Giampietro O
    Curr Med Chem; 2015; 22(13):1573-81. PubMed ID: 25723507
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dipeptidyl peptidase IV inhibitors: a new paradigm in type 2 diabetes treatment.
    Janardhan S; Sastry GN
    Curr Drug Targets; 2014 Jun; 15(6):600-21. PubMed ID: 24611684
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dipeptidyl peptidase 4 inhibitors and their potential immune modulatory functions.
    Shao S; Xu Q; Yu X; Pan R; Chen Y
    Pharmacol Ther; 2020 May; 209():107503. PubMed ID: 32061923
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Discovery of Novel DPP-IV Inhibitors as Potential Candidates for the Treatment of Type 2
    Musoev A; Numonov S; You Z; Gao H
    Molecules; 2019 Aug; 24(16):. PubMed ID: 31394858
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison between SGLT2 inhibitors and DPP4 inhibitors added to insulin therapy in type 2 diabetes: a systematic review with indirect comparison meta-analysis.
    Min SH; Yoon JH; Hahn S; Cho YM
    Diabetes Metab Res Rev; 2017 Jan; 33(1):. PubMed ID: 27155214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.